A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones

Clinical trial NCT04521361 · COMPLETED

Trial details

NCT number: NCT04521361
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bone Metastatic Castration-resistant Prostate Cancer

Start date: 2020-11-16
Primary completion: 2023-10-10
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.